Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: April 14, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.
Journal: Journal of the American College of Cardiology
Published: March 15, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: November 24, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Journal: Journal of the American College of Cardiology
Published: October 11, 2016
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.
Journal: Journal of the American College of Cardiology
Published: April 13, 2015
Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy.
Journal: Journal of cardiovascular translational research
Published: September 26, 2014
Perioperative beta-blockers in noncardiac surgery: the evidence continues to evolve.
Journal: Cleveland Clinic journal of medicine
Published: August 03, 2014
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
Journal: Circulation research
Published: February 26, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.
Journal: Circulation research
Published: January 23, 2014
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
Journal: JAMA
Published: November 20, 2013
Combination therapy for hypertension 2013: an update.
Journal: Journal of the American Society of Hypertension : JASH
Published: April 10, 2013
Last Updated: 09/26/2026